Real-world cross-validation of insurer and hospital price transparency data finds low overlap but high concordance between data sources. Given recent congressional interest in codifying price ...
BACKGROUND: The FINE-CKD model was developed to estimate the cost-effectiveness of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). OBJECTIVE: To perform internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback